Skip to Content
Print Share

Obagi (tretinoin topical) Disease Interactions

Drug Interactions (34) Disease Interactions (2)

There are 2 disease interactions with Obagi (tretinoin topical):

Major

Retinoid/Retinoid-Like Topical (Includes Obagi) ↔ Eczema

Severe Potential Hazard, High plausibility

Applies to: Eczema

Topical retinoids may cause severe irritation on eczematous skin. Therapy with topical retinoids should be avoided on abraded or eczematous skin.

References

  1. "Product Information. Differin (adapalene topical)." Galderma Laboratories Inc, Fort Worth, TX.
  2. "Product Information. Tazorac (tazarotene topical)." Allergan Inc, Irvine, CA.
  3. "Product Information. Retin-A (tretinoin)." Ortho Pharmaceutical Corporation, Raritan, NJ.
Moderate

Retinoid/Retinoid-Like Topical (Includes Obagi) ↔ Sunburn

Moderate Potential Hazard, High plausibility

Applies to: Sunburn

Retinoid-like products can cause extreme irritation when applied to sunburned skin. Patients with sunburn should be cautioned not to use retinoid-like acne products until fully recovered, and to avoid prolonged exposure to sunlight (including sunlamps) and use sunscreen/protective clothing during treatment with these products.

References

  1. "Product Information. Differin (adapalene topical)." Galderma Laboratories Inc, Fort Worth, TX.
  2. Rosenbluth M "Adverse reaction to retin-A." J Am Dent Assoc 119 (1989): 346
  3. "Product Information. Tazorac (tazarotene topical)." Allergan Inc, Irvine, CA.
  4. "Product Information. Retin-A (tretinoin)." Ortho Pharmaceutical Corporation, Raritan, NJ.
View all 4 references

Obagi (tretinoin topical) drug Interactions

There are 34 drug interactions with Obagi (tretinoin topical)

Drug Interaction Classification

The classifications below are a general guideline only. It is difficult to determine the relevance of a particular drug interaction to any individual given the large number of variables.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Drugs.com Mobile Apps

The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Available for Android and iOS devices.

Explore Apps
Hide